OC
PFE icon

Opinicus Capital’s Pfizer PFE Stock Holding History

Opinicus Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,422
Closed -$266K – 112
2025
Q3 		$266K Sell
10,422
-867
-8% -$21.4K 0.18% 93
2025
Q2 		$274K Sell
11,289
-4,363
-28% -$102K 0.21% 89
2025
Q1 		$397K Sell
15,652
-1,834
-10% -$48K 0.35% 73
2024
Q4 		$464K Sell
17,486
-20,431
-54% -$554K 0.39% 64
2024
Q3 		$1.1M Sell
37,917
-4,459
-11% -$130K 0.88% 36
2024
Q2 		$1.19M Buy
42,376
+2,303
+6% +$63.4K 1% 30
2024
Q1 		$1.11M Buy
40,073
+6,265
+19% +$174K 0.99% 32
2023
Q4 		$973K Buy
+33,808
New +$1.02M 0.99% 36

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Opinicus Capital's PFE Position: Q4 2025 in Review

Opinicus Capital sold out of Pfizer (PFE) in Q4 2025, closing a stake of 10,422 shares — an estimated $266K sold.

Opinicus Capital first reported a position in PFE in Q4 2023 and held it in 8 quarters. The position peaked at $1.19M in Q2 2024. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Opinicus Capital reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Opinicus Capital sold 10,422 Pfizer shares in Q4 2025, an estimated $266K.
  • Opinicus Capital first reported a position in Pfizer in Q4 2023 and held it in 8 quarters.
  • Opinicus Capital's Pfizer position peaked at $1.19M in Q2 2024.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Opinicus Capital's 13F filing for Q4 2025, filed 4 Feb 2026.